Sfoglia per AUTORE
POGGIO F
Collezione AO Cuneo

  

Items : 7

Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer Patients. in Journal of the National Cancer Institute / J Natl Cancer Inst. 2022 Mar 8;114(3):400-408. doi: 10.1093/jnci/djab213.

2022
AO Cuneo

Lambertini M; Boni L; Michelotti A; Magnolfi E; Cogoni AA; Mosconi AM; Giordano M; Garrone O; Arpino G; Poggio F; Cinacchi P; Bighin C; Fregatti P; Pronzato P; Blondeaux E; Del Mastro L;

Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial. in The Lancet. Oncology / Lancet Oncol. 2022 Dec;23(12):1571-1582. doi: 10.1016/S1470-2045(22)00632-5. Epub 2022 Nov 10.

2022
AO Cuneo
ASL Città di Torino

Lambertini M; Colantuoni G; Puglisi F; Montemurro F; Bighin C; Correale P; Poletti P; Mansutti M; Alicicco MG; Urracci Y; Gasparro S; Garrone O; Fabi A; Cognetti F; Vaccaro A; Nisticò C; Turletti A; Bisagni G; Rimanti A; Gravina A; De Laurentiis M; Forestieri V; Giuliano M; Blondeaux E; De Placido S; Poggio F; Boni L; Del Mastro L;

Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial. in The Lancet. Oncology / Lancet Oncol. 2021 Oct;22(10):1458-1467. doi: 10.1016/S1470-2045(21)00352-1. Epub 2021 Sep 17.

2021
AO Cuneo
AOU Città della Salute di Torino

Bruzzi P; Montemurro F; Ballestrero A; Lambertini M; Amaducci L; Campadelli E; Arpino G; Moretti G; Tamberi S; Bighin C; Puglisi F; Barone C; Garrone O; Fabi A; Gori S; De Placido S; Urracci Y; Sanna G; Mura S; Michelotti A; Poggio F; Frassoldati A; Cognetti F; Durando A; Ponzone R; Del Mastro L; Mansutti M; Bisagni G;

Final analysis of the PROMISEGIM6 phase III trial assessing GnRH agonist use during chemotherapy as a strategy to preserve ovarian function in premenopausal patients with early breast cancer in Journal of Clinical Oncology

2021
AO Cuneo

Garrone O; Arpino G; Mosconi AM; Lambertini M; Blondeaux E; Del Mastro L; Pronzato P; Bighin C; Fregatti P; Poggio F; Cinacchi P; Giordano M; Cogoni AA; Magnolfi E; Michelotti A; Boni L;

Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Sep;136:43-51. doi: 10.1016/j.ejca.2020.05.007. Epub 2020 Jul 4.

2020
AO Cuneo

Ceppi M; Boccardo F; Miglietta L; Cardinali B; Fregatti P; Montemurro F; Puglisi F; Garrone O; Gamucci T; De Placido S; Nisticò C; Cognetti F; Valle E; De Laurentiis M; Blondeaux E; Bighin C; Poggio F; Lambertini M; Bruzzone M; Conte B; Del Mastro L;

Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial. in International journal of cancer / Int J Cancer. 2020 Jul 1;147(1):160-169. doi: 10.1002/ijc.32789. Epub 2019 Dec 4.

2020
ASL Città di Torino
AO Cuneo
AOU Città della Salute di Torino

Del Mastro L; Ceppi M; Montemurro F; Puglisi F; Garrone O; Fabi A; Bisagni G; Durando A; Turletti A; Urracci Y; Cognetti F; De Laurentiis M; Giuliano M; Bighin C; de Azambuja E; Conte B; Poggio F; Bruzzone M; Lambertini M;

Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial. in JAMA / JAMA. 2015 Dec 22-29;314(24):2632-40. doi: 10.1001/jama.2015.17291.

2015
AO Cuneo

Boni L; Del Mastro L; Sertoli MR; Pronzato P; Vecchio C; Bighin C; Poggio F; Giraudi S; Giordano M; Gamucci T; Scotto T; Levaggi A; Garrone O; Gori S; Michelotti A; Lambertini M;